However, after further analysis, we found that the expression of YTHDC2, OAS1, IFIT2, and RAB5A had no significant relationship with the stage of tumor tissue (Fig. S10B), the patient's smoking habits (Fig. S10C), the presence of EGFR mutations (Fig. S10D), and whether the patient received preoperative treatment (including targeted therapy, immunotherapy, chemoradiotherapy, and so on) (Fig. S10E). This evidence concerns the gene YTHDC2 and neoplasm.